Skip to main content

UBS Group AG

Position in ARTL — Artelo Biosciences, Inc.

CIK 1610520 ZURICH, V8

Position in ARTL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,140
-$37,877 QoQ
Shares Held
312
-74.9% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 10 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. ARTL ranks #486 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ARTL

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,140 2,804
2025-12-31 $41,017 33,621
2025-09-30 $957 209
2025-06-30 $1,180 89
2025-03-31 $11,175 12,772
2024-12-31 $14,094 13,297
2024-03-31 $185 125
2023-09-30 $163 112
2023-03-31 $5,516 2,378
2022-12-31 $8,817 3,051
2022-09-30 $13,727 3,979
2022-06-30 $15,520 48,961
2022-03-31 $8,227 18,283
2021-06-30 $43,352 36,431
2021-03-31 $25,550 15,675
2020-03-31 $767 799